| Name | Title | Contact Details |
|---|
HealthCarts.com is a Plymouth, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vital Signs, Inc. is a designer, manufacturer, and marketer of airway management products for the anesthesia, respiratory/critical care, interventional cardiology/radiology and sleep disorder markets. The Company sells its products in over 73 countries
XACT Robotics® is a privately held company focused on advancing the field of radiology by developing the world`s first and only hands-free robotic solutions that can significantly improve targeting accuracy, efficiency, and consistency in percutaneous radiology procedures. The company was founded in 2013 by Harel Gadot, a renowned entrepreneur in the MedTech robotics space, whose vision reimagined how image-guided percutaneous procedures are performed. At XACT, we embrace the philosophy of collaboration, tenacity, and extreme ownership. Our family culture empowers and inspires as we partner, develop, and execute meaningful technologies to make a difference in the lives of patients. Our company`s leadership is comprised of start-up, robotic, and disruptive technology experts with deep knowledge, vast experience and the diverse leadership skills required in the robotic market.
Centurion Medical Products is a Williamston, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotrispy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. In peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, IVL demonstrated safety and consistent procedure success with low procedural complications. The technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatments. And because it is built on a traditional balloon catheter platform, it integrates seamlessly with clinicians` existing workflow.